Education
About Us
Working with TipRanks
Follow Us
Stuart Poulton Insider Profile
4 Followers
Stuart Poulton, EVP, Chief Development Officer at Karyopharm Therapeutics, holds 67.39K shares in Karyopharm Therapeutics (Ticker: KPTI).
Stuart Poulton has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Roles
EVP, Chief Development Officer
Roles that Stuart Poulton holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Feb 17, 2023 - Feb 17, 2024
Return:+64.20%
The most profitable trade made by Stuart Poulton
Stuart Poulton's Trading History
List of latest transactions for each holding click on a transaction to see Stuart Poulton's performance on stock
You May Also Like
Stuart Poulton insider profile FAQ
What is the percentage of profitable transactions made by Stuart Poulton?
The percentage of profitable transactions made by Stuart Poulton is ―.
What is the average return per transaction made by Stuart Poulton?
The average return per transaction made by Stuart Poulton is ―.
What stocks does Stuart Poulton hold?
Stuart Poulton holds: KPTI stocks.
What was Stuart Poulton’s latest transaction?
Stuart Poulton latest transaction was an Uninformative Buy of ―.
What was Stuart Poulton's most profitable transaction?
Stuart Poulton’s most profitable transaction was an Informative Sell of KPTI stock on February 17, 2023. The return on the trade was 64.20%.
What is Stuart Poulton's role in Karyopharm Therapeutics?
Stuart Poulton's role in Karyopharm Therapeutics is EVP, Chief Development Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.